Experience with cyclosporine

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S54-S58

  Curtis, J J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

ALLOGRAFT; ARTICLE; CLINICAL TRIAL; FIBROSIS; HAIR GROWTH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; KIDNEY DISEASE; LIVER TOXICITY; NEPHROTOXICITY; PHYSICIAN; POLYPHARMACY; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; TRANSPLANTATION;

EID: 1642370669     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.12.044     Document Type: Article

References (36)

1. Flechner S.M., Payne W.D., Van Buren C., et al. The effect of cyclosporine on early graft function in human renal transplantation. Transplantation. 36:1983;268.
2. Cho S.I., Bradley A.P., Monaco A.P., et al. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin. Am J Surg. 147:1984;518.
3. Barry J.M. Immunosuppressive drugs in renal transplantation. A review of the regimens. Drugs. 44:1992;554.
4. Krensky A.M., Clayberger C. Prospects for induction of tolerance in renal transplantation. Pediatr Nephrol. 8:1994;772.
5. Sutherland D.E., Strand M., Fryd D.S., et al. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation. Am J Kidney Dis. 3:1984;456.
6. Stiller C.R. Update for the Canadian multicentre trial of cyclosporine in renal allografts. N Engl J Med. 310:1984;1464.
7. European Multicentre Trial of Cyclosporine in Renal Transplantation: 10-Year Follow-Up. Transplant Proc 25: 527, 1993.
8. Hunksicker L.G. Impact of cyclosporine on cadaveric renal transplantation a summary statement. Am J Kidney Dis. 5:1985;335.
9. Evans R.W., Manninem D.L. Economic impact of cyclosporine in transplantation. Transplant Proc. 20:(suppl 3):1988;49.
10. Walsh J. House panel denies exception for drug. Science. 223:1984;1374.
11. Bennett W.M. The nephrotoxicity of immunosuppressive drugs. Clin Nephrol. 43:(suppl 1):1995;S3.
12. Cronin R.E. Aminoglycoside nephrotoxicity pathogenesis and prevention. Clin Nephrol. 11:1979;251.
13. Pirsch J.D., D'Alessandro A.M., Sollinger H.W., et al. Hyperlipidemia and transplantation etiologic factors and therapy. J Am Soc Nephrol. 2:(suppl 12):1992;S238.
14. Remuzzi G., Perico N. Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int. 52:(suppl 1):1995;S70.
15. Gonwa T.A., Mai M.L., Melton L.B., et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy risk of development and treatment. Transplantation. 72:2001;1934.
16. Darlametsos I.E., Varonos D.D. Role of prostanoids and endothelins in the prevention of cyclosporine-induced nephrotoxicity. Prostaglandins Leukot Essent Fatty Acids. 64:2001;231.
17. Waiser J., Dell K., Bohler T., et al. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Nephrol Dial Transplant. 17:2002;1568.
18. Rush D., Nickerson P., Gough J., et al. Beneficial effects of treatment of early subclinical rejection a randomized study. J Am Soc Nephrol. 9:1998;2129.
19. Miller L.W. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant. 2:2002;807.
20. Curtis J, Luke R, Jones P, et al: Transplant hypertension with cyclosporine is sodium sensitive and less responsive to captopril than with azathioprine. National Kidney Foundation Meeting, Washington, D.C., 1986. (abstract).
21. Luke R.G. Essential hypertension a renal disease? A review and update of the evidence. Hypertension. 21:1993;380.
22. Curtis J.J., Galla J.H., Woodford S.Y., et al. Effect of alternate-day prednisone on plasma lipids in renal transplant recipients. Kidney Int. 22:1982;42.
23. Ballantyne C.M., Podet E.J., Patsch W.P., et al. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 262:1989;53.
24. Gill J.S., Abichandani R., Kausz A.T., et al. Mortality after kidney transplant failure the impact of non-immunologic factors. Kidney Int. 62:2002;1875.
25. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 7:1996;158.
26. Arend S.M., Mallat M.J., Westendorp R.J.W., et al. Patient survival after renal transplantation more than 25 years follow-up. Nephrol Dial Transplant. 12:1997;1672.
27. Grossman R.M., Chevret S., Abi-Rached J., et al. Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol. 132:1996;623.
28. Ferguson R.M., Sommer B.G. Cyclosporine in renal transplantation a single institutional experience. Am J Kidney Dis. 5:1985;296.
29. Grevel J., Welsh M.S., Kahan B.D. Cyclosporine monitoring in renal transplantation area under the curve monitoring is superior to trough-level monitoring. Ther Drug Monit. 11:1989;246.
30. Henry M.L., Tesi R.J., Elkhammas E.A., et al. A randomized, prospective, double- blinded trial of cyclosporine vs. OG37-325 in cadaveric renal transplantation-a preliminary report. Transplanta-tion. 55:1993;748.
31. Duncan J.I., Thomson A.W., Simpson J.G., et al. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats. Transplantation. 42:1986;395.
32. Meier-Kriesche H.U., Swinford R., Kahan B.D., et al. Reduced variability of neoral pharmacokinetic studies in pediatric renal transplantation. Pediatr Nephrol. 15:2000;2.
33. Cole E., Maham N., Cardella C., et al. Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients. Transplantation. 75:2003;2086.
34. Bartucci M.R. Issues in cyclosporine drug substitution implications for patient management. J Transpl Coord. 9:1999;137.
35. Salaman J. Cyclosporine mono-drug therapy. Transplant Proc. 20:(suppl 3):1988;117.
36. Stratta R.J., D'Alessandro A.M., Hoffmann R.M., et al. Cadaveric renal transplantation in the cyclosporine and OKT3 eras. Surgery. 104:1988;606.